Outsourcing

Editor of Pharmaceutical Technology Europe

Articles

Dosage form priorities are shifting to focus on user-friendliness, leading to greater engagement with outsourcing partners earlier in development timelines.

Putting the Patient at the Heart of Dosage Form Design

Collaborative partnerships can foster success in formulation development projects.

Developing the Best Formulation Partnership 

Sara Sefton is technical manager, pharmaceutical development, Vectura.

Fergus Manford is patent attorney, intellectual property, Vectura.

Tim Gardner is director, manufacturing and NPI, Vectura.

Andrew Walker is vice president, device development, Vectura.

The choice of delivery platform for inhaled drug products is contingent on API-related factors, as well as the development stage of the product. 

Integrated Approach Facilitates Inhalation Drug Development

Craig A. Steger is SVP–Life Sciences at Outcome Capital LLC, 99 High St., Suite 2900, Boston MA.

Thomas J. Joyce is Associate at Outcome Capital LLC, 99 High St., Suite 2900, Boston MA.

Oded Ben-Joseph, PhD, is Managing Director, at Outcome Capital LLC, 99 High St., Suite 2900, Boston MA.

The CRO market will see greater consolidation by both financial buyers looking to consolidate smaller players and larger CRO players wanting to expand into value-added specialty service areas.

Pharma Services Sector Poised for Continued Growth and Consolidation

The companies will utilize the Cocoon Platform for clinical point-of-care manufacturing.

Lonza and CellPoint Collaborate to Develop T-cell Based Therapies

The companies have entered into an agreement to develop processes for a novel immunotherapy protein.

SelectImmune and Lonza to Develop Immunotherapeutic Drug Candidate

Vectura has signed an agreement with Incannex Healthcare for the pre-clinical development of IHL-216A, an inhaled drug product for the treatment of traumatic brain injury.

Vectura Signs Agreement with Incannex to Advance TBI Treatment

Thought and foresight into method development stages can ensure costly errors and delays are avoided later on.

Outlining the Key Steps to Method Development

Outsourcing method development offers multiple benefits to companies, including access to experience and expertise, streamlined costs, and development time efficiencies.

Developing a Method for Success through Partnerships

Xueqiang (Cliff) Yin is executive director, CMC Project Management, STA Pharmaceutical, a WuXi AppTec Company (WuXi STA).

An integrated CMC provider can help smaller companies to streamline development timelines and reduce project management complexity when compared with multi-provider models.

Contract Development Services